Classification and Growth Rate of Chorioretinal Atrophy after Voretigene Neparvovec-Rzyl for RPE65-Mediated Retinal Degeneration

被引:5
作者
Bommakanti, Nikhil [1 ]
Young, Benjamin K. [1 ]
Sisk, Robert A. [2 ,3 ,4 ]
Berrocal, Audina M. [5 ]
Duncan, Jacque L. [6 ]
Bakall, Benjamin [7 ]
Mathias, Marc T. [8 ]
Ahmed, Ishrat [9 ]
Chorfi, Sarah [9 ]
Comander, Jason [9 ]
Nagiel, Aaron [10 ,11 ]
Besirli, Cagri G. [1 ]
机构
[1] Univ Michigan, WK Kellogg Eye Ctr, Med Sch, Dept Ophthalmol & Visual Sci, Ann Arbor, MI USA
[2] Cincinnati Eye Inst, Cincinnati, OH USA
[3] Univ Cincinnati, Dept Ophthalmol, Cincinnati, OH USA
[4] Cincinnati Childrens Hosp Med Ctr, Abrahamson Pediat Eye Inst, Cincinnati, OH USA
[5] Univ Miami, Bascom Palmer Eye Inst, Miami, FL USA
[6] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA USA
[7] Associated Retina Consultants, Phoenix, AZ USA
[8] Univ Colorado, Denver Sch Med, Dept Ophthalmol, Aurora, CO USA
[9] Harvard Med Sch, Ocular Genom Inst, Dept Ophthalmol, Massachusetts Eye & Ear, Boston, MA USA
[10] Childrens Hosp Los Angeles, Vis Ctr, Dept Surg, Los Angeles, CA 90027 USA
[11] Univ Southern Calif, Roski Eye Inst, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90007 USA
来源
OPHTHALMOLOGY RETINA | 2024年 / 8卷 / 01期
关键词
Chorioretinal atrophy; Gene therapy; Leber congenital amaurosis; Luxturna; Voretigene neparvovec-rzyl; MACULAR DEGENERATION; GENE-THERAPY; RPE65; ISOMEROHYDROLASE; DYSTROPHY;
D O I
10.1016/j.oret.2023.08.017
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: Classify the appearance and quantify the growth rate of chorioretinal atrophy in patients who received voretigene neparvovec-rzyl (VN) for RPE65-mediated retinal degeneration. Design: Multicenter retrospective analysis. Subjects: Patients who underwent subretinal VN injection at 5 institutions and demonstrated posterior-pole chorioretinal atrophy. Methods: Ultrawidefield scanning laser ophthalmoscopy or color fundus photos were assessed before and after subretinal VN. Atrophy was defined as regions with > 2 of the following: (1) partial or complete retinal pigment epithelial depigmentation; (2) round shape; (3) sharp margins; and (4) increased visibility of choroidal vessels. Atrophy was qualitatively classified into different subtypes. All atrophy was manually segmented. Linear mixed-effects models with random slopes and intercepts were fit using atrophy area and square root of atrophy area. Main Outcome Measures: Number of eyes with each atrophy pattern, and slopes of linear mixed-effects models. Results: Twenty-seven eyes from 14 patients across 5 centers developed chorioretinal atrophy after subretinal VN. A mean of 5.8 +/- 2.7 images per eye obtained over 2.2 +/- 0.8 years were reviewed, and atrophy was categorized into touchdown (14 eyes), nummular (15 eyes), and perifoveal (12 eyes) subtypes. Fifteen eyes demonstrated > 1 type of atrophy. Thirteen of 14 patients demonstrated bilateral atrophy. The slopes of the mixed-effects models of atrophy area and square root of atrophy area (estimate +/- standard error) were 1.7 +/- 1.3 mm(2)/year and 0.6 +/- 0.2 mm/year for touchdown atrophy, 5.5 +/- 1.3 mm(2)/year and 1.2 +/- 0.2 mm/year for nummular atrophy, and 16.7 +/- 1.8 mm(2)/year and 2.3 +/- 0.2 mm/year for perifoveal atrophy. The slopes for each type of atrophy were significantly different in the square root of atrophy model, which best fit the data (P < 0.05). Conclusions: Chorioretinal atrophy after subretinal VN for RPE65-mediated retinal degeneration developed according to a touchdown, nummular, and/or perifoveal pattern. Perifoveal atrophy grew the most rapidly, while touchdown atrophy grew the least rapidly. Understanding the causes of these findings, which are present in a minority of patients, merits further investigation. (c) 2023 by the American Academy of Ophthalmology
引用
收藏
页码:42 / 48
页数:7
相关论文
共 21 条
[1]   Reply to Townes-Anderson: RPE65 gene therapy does not alter the natural history of retinal degeneration [J].
Cideciyan, Artur V. ;
Jacobson, Samuel G. ;
Beltran, William A. ;
Hauswirth, William W. ;
Aguirre, Gustavo D. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (19) :E1706-E1706
[2]   Precise Montaging and Metric Quantification of Retinal Surface Area From Ultra-Widefield Fundus Photography and Fluorescein Angiography [J].
Croft, Daniel E. ;
van Hemert, Jano ;
Wykoff, Charles C. ;
Clifton, David ;
Verhoek, Michael ;
Fleming, Alan ;
Brown, David M. .
OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2014, 45 (04) :312-317
[3]   Methods and Reproducibility of Grading Optimized Digital Color Fundus Photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2) [J].
Danis, Ronald P. ;
Domalpally, Amitha ;
Chew, Emily Y. ;
Clemons, Traci E. ;
Armstrong, Jane ;
SanGiovanni, John Paul ;
Ferris, Frederick L., III .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (07) :4548-4554
[4]  
Food and Drug Administration, 2019, about us
[5]   Perifoveal Chorioretinal Atrophy after Subretinal Voretigene Neparvovec-rzyl for RPE65-Mediated Leber Congenital Amaurosis [J].
Gange, William S. ;
Sisk, Robert A. ;
Besirli, Cagri G. ;
Lee, Thomas C. ;
Havunjian, Margaret ;
Schwartz, Hillary ;
Borchert, Mark ;
Sengillo, Jesse D. ;
Mendoza, Carlos ;
Berrocal, Audina M. ;
Nagiel, Aaron .
OPHTHALMOLOGY RETINA, 2022, 6 (01) :58-64
[6]   Imaging Protocols in Clinical Studies in Advanced Age-Related Macular Degeneration [J].
Holz, Frank G. ;
Sadda, SriniVas R. ;
Staurenghi, Giovanni ;
Lindner, Moritz ;
Bird, Alan C. ;
Blodi, Barbara A. ;
Bottoni, Ferdinando ;
Chakravarthy, Usha ;
Chew, Emily Y. ;
Csaky, Karl ;
Curcio, Christine A. ;
Danis, Ron ;
Fleckenstein, Monika ;
Freund, K. Bailey ;
Grunwald, Juan ;
Guymer, Robyn ;
Hoyng, Carel B. ;
Jaffe, Glenn J. ;
Liakopoulos, Sandra ;
Mones, Jordi M. ;
Oishi, Akio ;
Pauleikhoff, Daniel ;
Rosenfeld, Philip J. ;
Sarraf, David ;
Spaide, Richard F. ;
Tadayoni, Ramin ;
Tufail, Adnan ;
Wolf, Sebastian ;
Schmitz-Valckenberg, Steffen .
OPHTHALMOLOGY, 2017, 124 (04) :464-478
[7]   Leber congenital amaurosis/early-onset severe retinal dystrophy: clinical features, molecular genetics and therapeutic interventions [J].
Kumaran, Neruban ;
Moore, Anthony T. ;
Weleber, Richard G. ;
Michaelides, Michel .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2017, 101 (09) :1147-1154
[8]   RPE65 is the isomerohydrolase in the retinoid visual cycle [J].
Moiseyev, G ;
Chen, Y ;
Takahashi, Y ;
Wu, BX ;
Ma, JX .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (35) :12413-12418
[9]   Mutation of key residues of RPE65 abolishes its enzymatic role as isomerohydrolase in the visual cycle [J].
Redmond, TM ;
Poliakov, E ;
Yu, S ;
Tsai, JY ;
Lu, ZJ ;
Gentleman, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (38) :13658-13663
[10]   Development of retinal atrophy after subretinal gene therapy with voretigene neparvovec [J].
Reichel, Felix Friedrich ;
Seitz, Immanuel ;
Wozar, Fabian ;
Dimopoulos, Spyridon ;
Jung, Ronja ;
Kempf, Melanie ;
Kohl, Susanne ;
Kortum, Friederike Charlotte ;
Ott, Saskia ;
Pohl, Lisa ;
Stingl, Krunoslav ;
Bartz-Schmidt, Karl Ulrich ;
Stingl, Katarina ;
Fischer, M. Dominik .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2023, 107 (09) :1331-1335